JSC Grindeks invested €1.87 million to expand finished dosage form packaging capacity

Category: News

JSC Grindeks invested €1.87 million to expand finished dosage form packaging capacity

JSC Grindeks has invested €1.87 million in a new packaging line at JSC Tallinna Farmaatsiatehas. During its first eight months of operation, the line produced...
13/10/2026
→

JSC Grindeks subsidiary Ltd Grindeks Kalceks in Lithuania receives “Strongest in Lithuania 2026” recognition

JSC Grindeks’ subsidiary in Lithuania Ltd Grindeks Kalceks has received the “Strongest in Lithuania 2026” (Stipriausi Lietuvoje) recognition, confirming the company’s financial stability, reliability and...
07/10/2026
→

JSC Grindeks Expands into the UK Market with First Topical Corticosteroid Product Registration

JSC Grindeks is pleased to announce a significant milestone in its product portfolio expansion: the successful registration of betamethasone valerate cream in the United Kingdom....
21/04/2026
→

Cardiologist and RSU Associate Professor Kārlis Trušinskis receives prestigious D. H. Grindel Award

On March 26, one of the most significant events in the Latvian healthcare sector, the ceremonial “Medical Excellence Awards” took place at the Splendid Palace...
30/03/2026
→

Grindeks Group introduces CDMO and out-licensing services

Over the last decade, Grindeks has been focusing on its own brand portfolio, but under the new CEO we are shifting our business development strategy....
02/12/2025
→

Jānis Romanovskis Appointed as CEO of JSC “Grindeks”

Changes have taken place in the Management Board of JSC Grindeks – Jānis Romanovskis has been appointed as the company’s Chairman of the Board. Romanovskis’...
12/08/2025
→

Strong growth and strengthened market positions in Europe during the first half of Grindeks final transformation year

Financial results for “Grindeks” show that in the first half of 2025 – the company’s final year of transformation – the Group has achieved significant...
06/08/2025
→

Endocrinologist and RSU Professor Ilze Konrade – This year’s D. H. Grindel award laureate

On Wednesday, 26 March, the prestigious “Annual Medicine Award” ceremony was held at the Splendid Palace cinema – one of the most significant events in...
27/03/2025
→

Grindeks honours excellence in pharmacy and medicine for 30 years

On March 26, the Latvian pharmaceutical company Grindeks will present the prestigious D. H. Grindel Award – the highest professional recognition for significant or lifetime...
13/03/2025
→

Baltics leading pharmaceutical company Grindeks expands to new export markets worldwide

The leading pharmaceutical company in the Baltics, Grindeks, continues to strengthen its global presence by entering new export markets. This year, for the first time,...
20/02/2025
→

Grindeks supports the 32nd A. Krauklis Memorial Basketball Tournament

This year, “Grindeks” will support the 32nd Alfrēds Krauklis Memorial Basketball Tournament, which is the largest children’s and youth basketball event in the Baltics. The...
15/08/2024
→

Grindeks – 2nd best employer in the manufacturing sector

The TOP Employer survey, in which the best employers in Latvia were determined, has concluded with an award ceremony. With great pleasure and gratitude to...
10/04/2024
→
Grindeks_Razotnes9

Grindeks promotes the development of the pharmaceutical industry

In recent years, Latvia has faced a shortage of graduates in various fields of exact sciences. The statistics reveal that young people are rarely choosing...
18/07/2023
→

Grindeks convincing development in international markets

Grindeks is the leading pharmaceutical company in the Baltic states that has reached a stage of development at the level, where strategic thinking and significant...
03/07/2023
→

Grindeks holds first International Charity day

On May 15th, Grindeks International Charity day was held for the first time, during which 60 seniors from three Latvian counties made an organized, exploratory...
31/05/2023
→
1 2 3 … 17
magnifiercrossmenu